Entrada Therapeutics Inc (TRDA) Insider Trading
- $923,397.49
- $3,347,384.30
- Oct. 16, 2024
- Dipal Doshi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 16, 2024 | Insider | 600 | $18.00 | Sell | $10,800.00 | |
Sept. 26, 2024 | COO | 847 | $16.00 | Sell | $13,552.00 | |
Sept. 9, 2024 | CFO | 3,195 | $14.97 | Sell | $47,829.15 | |
Sept. 9, 2024 | Insider | 2,642 | $15.09 | Sell | $39,867.78 | |
Sept. 9, 2024 | COO | 1,904 | $15.07 | Sell | $28,693.28 | |
Sept. 6, 2024 | Insider | 600 | $15.24 | Sell | $9,144.00 | |
Sept. 6, 2024 | COO | 399 | $15.19 | Sell | $6,060.81 | |
July 15, 2024 | Insider | 638 | $18.00 | Sell | $11,484.00 | |
July 15, 2024 | CEO | 1,600 | $17.81 | Sell | $28,496.00 | |
July 12, 2024 | Insider | 600 | $18.00 | Sell | $10,800.00 | |
July 12, 2024 | CEO | 300 | $18.00 | Sell | $5,400.00 | |
July 8, 2024 | CFO | 1,758 | $14.95 | Sell | $26,282.10 | |
June 13, 2024 | CEO | 1,000 | $16.17 | Sell | $16,170.00 | |
May 20, 2024 | Insider | 9,675 | $15.19 | Sell | $146,963.25 | |
May 16, 2024 | CEO | 1,800 | $15.00 | Sell | $27,000.00 | |
May 16, 2024 | Insider | 1,000 | $15.00 | Sell | $15,000.00 | |
May 8, 2024 | Director | 2,276 | $14.04 | Buy | $31,955.04 | |
April 8, 2024 | Director | 2,600 | $13.57 | Buy | $35,282.00 | |
March 28, 2024 | Director | 1,512 | $13.75 | Buy | $20,790.00 | |
March 25, 2024 | Director | 3,180 | $13.36 | Buy | $42,484.80 | |
March 21, 2024 | Director | 704 | $13.24 | Buy | $9,320.96 | |
March 19, 2024 | Director | 900 | $12.66 | Buy | $11,394.00 | |
Feb. 15, 2024 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Jan. 16, 2024 | CEO | 1,000 | $15.99 | Sell | $15,990.00 | |
Dec. 26, 2023 | CFO | 94 | $16.67 | Sell | $1,566.98 | |
Dec. 22, 2023 | CFO | 10,206 | $15.69 | Sell | $160,132.14 | |
Dec. 20, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Nov. 13, 2023 | CEO | 1,000 | $16.23 | Sell | $16,230.00 | |
Oct. 17, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 13, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 6, 2023 | COO | 972 | $13.47 | Sell | $13,092.84 | |
Sept. 6, 2023 | Insider | 892 | $13.48 | Sell | $12,024.16 | |
Sept. 6, 2023 | CFO | 950 | $13.48 | Sell | $12,806.00 | |
Aug. 14, 2023 | CEO | 1,000 | $15.67 | Sell | $15,670.00 | |
Aug. 4, 2023 | Insider | 6,898 | $14.14 | Sell | $97,537.72 | |
Aug. 2, 2023 | Insider | 10,348 | $15.19 | Sell | $157,186.12 | |
July 11, 2023 | CFO | 3,884 | $18.00 | Sell | $69,912.00 | |
July 10, 2023 | COO | 3,200 | $18.00 | Sell | $57,600.00 | |
July 10, 2023 | Insider | 3,026 | $18.00 | Sell | $54,468.00 | |
June 22, 2023 | COO | 7,097 | $16.02 | Sell | $113,693.94 | |
June 21, 2023 | CFO | 17,500 | $15.01 | Sell | $262,675.00 | |
June 20, 2023 | COO | 8,885 | $14.94 | Sell | $132,741.90 | |
April 27, 2023 | CEO | 2,000 | $13.71 | Sell | $27,420.00 | |
April 17, 2023 | Insider | 3,961 | $18.00 | Sell | $71,298.00 | |
April 17, 2023 | CEO | 2,092 | $18.01 | Sell | $37,676.92 | |
March 27, 2023 | CEO | 2,000 | $14.72 | Sell | $29,440.00 | |
Jan. 27, 2023 | CEO | 2,000 | $12.00 | Sell | $24,000.00 | |
Jan. 9, 2023 | CEO | 2,410 | $15.02 | Sell | $36,198.20 | |
Dec. 29, 2022 | CEO | 400 | $15.01 | Sell | $6,004.00 | |
Dec. 27, 2022 | CEO | 9,669 | $15.02 | Sell | $145,228.38 |
Insiders are both buying and selling Entrada Therapeutics Inc stock.
The insider traders at Entrada Therapeutics Inc are: Dipal Doshi, Nathan J Dowden, Kory James Wentworth, Nerissa Kreher, Natarajan Sethuraman, Peter S Kim, Bros. Advisors Lp Baker, and John F Crowley
The most active insider trader at Entrada Therapeutics Inc is Dipal Doshi with 32 trades.
Dipal Doshi has sold the most Entrada Therapeutics Inc stock with a total value of $926,283.49.
Bros. Advisors Lp Baker has bought the most Entrada Therapeutics Inc stock with a total value of $969,149.33.
The most recent insider trade for Entrada Therapeutics Inc was on Oct. 16, 2024.
The single biggest insider buy for Entrada Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $245,528.64 on June 6, 2022.
The single biggest insider sell for Entrada Therapeutics Inc was from Kory James Wentworth with a total value of $262,675.00 on June 21, 2023.